default author photo

Hua-qing Wang

Government of the People's Republic of China - Tianjin People's Hospital

Tianjin

China

SCHOLARLY PAPERS

1

DOWNLOADS

44

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Bortezomib in Combination with Fludarabine and Cyclophosphamide for Patients with Relapsed or Refractory Mantle-Cell Lymphoma: Results of the LYM-4003 Study

Number of pages: 75 Posted: 21 Aug 2019
Xiao-xiao Wang, Yan Gao, Jie Jin, Jun-ning Cao, Ji-feng Feng, Hua-qing Wang, Hui-lai Zhang, Qing-Qing Cai, Zhi-ming Li, Wen-Qi Jiang, Hui-Qiang Huang, Hui-Qiang Huang and Lymphoma Committee Chinese Anti-Cancer Association CACA
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Zhejiang University - Department of Hematology, Fudan University - Department of Medical Oncology, Jiangsu Cancer Hospital - Department of Medical Oncology, Government of the People's Republic of China - Tianjin People's Hospital, Tianjin Cancer Hospital, Sun Yat-sen University (SYSU) - Department of Medical Oncology, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Medical OncologySun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Independent
Downloads 44 (1,145,425)

Abstract:

Loading...

bortezomib, fludarabine, cyclophosphamide, relapsed or refractory, mantle-cell lymphoma